Insider trades

Hans van Houte, CFO of Nurix Therapeutics NRIX, has filed 0 purchases and 32 sales on the open market. Over the past 12 months that comes to a net sale of $452.9K. The latest trade was on 05/05.

Hans van Houte

CFO
First filing
23/02/01
Trades
114 trades
Buys / sales
0 / 32
12-month net buying
−$452.9K
Last trade
05/05

Trading activity

Transactions

Trade type
NRIX
Open-market sale10b5-1 plan05/0505/0514,055 sh2 trades$16.60avg.$233,381.1−27.2%
Open-market sale04/3004/302,388 sh$16.65$39,760.2−4.4%
NRIX
Open-market sale01/3001/303,661 sh2 trades$16.60avg.$60,757.05−7.5%
Open-market sale10b5-1 plan25/11/0325/11/036,284 sh$12.56$78,927.04−14.3%
Open-market sale25/10/3025/10/303,130 sh$12.80$40,064−6.7%
Open-market sale10b5-1 plan25/08/0125/08/015,402 sh$11.03$59,584.06−13.2%
Open-market sale25/07/3025/07/304,304 sh$12.01$51,691.04−9.5%
Open-market sale10b5-1 plan25/05/0225/05/026,198 sh$11.33$70,223.34−15.5%
Open-market sale25/04/3025/04/302,438 sh$11.50$28,037−5.8%
NRIX
Open-market sale10b5-1 plan25/03/0325/03/035,825 sh2 trades$14.49avg.$84,391−14.7%
NRIX
Open-market sale25/01/3025/01/302,811 sh2 trades$19.86avg.$55,817.99−6.6%
Open-market sale10b5-1 plan24/11/0124/11/013,546 sh$24.28$86,096.88−9.5%
Open-market sale24/10/3024/10/302,368 sh$24.31$57,566.08−6.0%
Open-market sale10b5-1 plan24/08/2624/08/2620,000 sh$25.22$504,400−39.2%
NRIX
Open-market sale10b5-1 plan24/08/0124/08/013,477 sh2 trades$21.45avg.$74,591.11−6.4%
Open-market sale24/07/3024/07/302,490 sh$20.67$51,468.3−4.4%
Open-market sale10b5-1 plan24/06/2024/06/2020,000 sh$20.01$400,200−29.3%
Open-market sale10b5-1 plan24/05/0224/05/023,499 sh$12.83$44,892.17−4.9%
Open-market sale24/04/3024/04/301,387 sh$12.04$16,699.48−1.9%
Open-market sale10b5-1 plan24/02/1624/02/166,812 sh$10.02$68,256.24−9.1%